Acetazolamide

Product NDC
68083-661
11-digit product format
680830661
Labeler code
68083
Product ID
68083-661_de1a5d68-b82d-4a84-9362-f7edd73f377a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Acetazolamide
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Gland Pharma Limited
Application
ANDA219775
Marketing category
ANDA
Marketing start
2025-06-17
Substance
ACETAZOLAMIDE SODIUM
Active strength
500 mg/5mL
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219775-001ACETAZOLAMIDE SODIUMACETAZOLAMIDE SODIUMEQ 500MG BASE/VIALINJECTABLE / INJECTIONAP2025-06-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A219775-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A219775-001ACETAZOLAMIDE SODIUMEQ 500MG BASE/VIALINJECTABLE / INJECTIONAP2025-06-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219775-001ACETAZOLAMIDE SODIUMEQ 500MG BASE/VIALINJECTABLE / INJECTIONAP2025-06-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A219775-001ACETAZOLAMIDE SODIUMEQ 500MG BASE/VIALINJECTABLE / INJECTIONAP2025-06-176a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219775-001ACETAZOLAMIDE SODIUMEQ 500MG BASE/VIALINJECTABLE / INJECTIONAP2025-06-17a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A219775-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219775-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A219775-001AP16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219775-001AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Acetazolamide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACETAZOLAMIDE SODIUM500 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
429ZT169UHInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
307702Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2b9fb0dd-e42e-4f9b-bf24-98b268d877e5Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
94b5d997-68ee-d92e-7c04-a34fdb427a66Product name920240509
d0adda24-c2d3-39f8-a845-ede9cd56b2c4Product name620210513
91efc97d-7785-4097-b6cf-4201369f41ebProduct name320190711

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68083-661-01Acetazolamide5 mL in 1 VIALINJECTION, POWDER, LYOPHILIZED,53
68083-661-01Acetazolamide1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AcetazolamideACETAZOLAMIDE SODIUMSagent Pharmaceuticals58093032-8480-4d0f-82be-92e643bdbea42026-01-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219775
application number: ANDA219775
AcetazolamideACETAZOLAMIDEGland Pharma Limited2b9fb0dd-e42e-4f9b-bf24-98b268d877e52025-06-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219775
application number: ANDA219775
ndc (product): 68083-661

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
307702acetaZOLAMIDE 500 MG InjectionPSN2b9fb0dd-e42e-4f9b-bf24-98b268d877e53
307702acetazolamide 500 MG InjectionSCD2b9fb0dd-e42e-4f9b-bf24-98b268d877e53
307702acetazolamide (as acetazolamide sodium) 500 MG InjectionSY2b9fb0dd-e42e-4f9b-bf24-98b268d877e53

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
68083-661-01680830661011 VIAL in 1 CARTON (68083-661-01) / 5 mL in 1 VIAL1 vial2025-06-17NoNoCurrent